» Articles » PMID: 11312141

Immunocytochemical Demonstration of Oestrogen Receptor Beta in Blood Vessels of the Female Rat

Overview
Journal J Endocrinol
Specialty Endocrinology
Date 2001 Apr 20
PMID 11312141
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The role of oestrogen receptor (ER) beta in vascular function remains unclear. With the use of a specific ERbeta antibody we have now, using immunocytochemistry, visualized ERbeta in different parts of the vascular tree. In about 70% of medial smooth muscle cells of female rat aorta, tail artery and uterine artery, nuclear immunoreactivity to ERbeta was observed. In these vessels endothelial cells also expressed ERbeta. Vascular expression of the ERalpha subtype was lower than that of ERbeta. In aorta and tail artery, no immunoreactivity towards ERalpha was observed, while in uterine vessels occasional medial smooth muscle and endothelial cells expressed this ER subtype. ERbeta and alpha expression in uterine vessels was independent of the stage of the oestrous cycle, suggesting that variations in uterine blood flow occurring during the cycle are independent of ER density. The regional distribution of ERalpha, as determined by immunocytochemistry, was supported by measurements of ERalpha levels by enzyme immunoassay. In the uterine artery, the level of ERalpha was several times higher (P<0.001) than that of aorta and tail artery (10.1+/-1.7 fmol/mg protein in the uterine artery vs 3.3+/-1.0 and 0.5+/-0.5 fmol/mg protein in aorta and tail artery respectively). Thus, a prominent nuclear expression of ERbeta was observed in the vascular wall of several parts of the vascular tree, while ERalpha predominantly was expressed in uterine vessels, suggesting that ERbeta and alpha may have different roles in vascular function.

Citing Articles

Gender-based research underscores sex differences in biological processes, clinical disorders and pharmacological interventions.

Bernstein S, Kelleher C, Khalil R Biochem Pharmacol. 2023; 215:115737.

PMID: 37549793 PMC: 10587961. DOI: 10.1016/j.bcp.2023.115737.


Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension.

Sun Y, Sangam S, Guo Q, Wang J, Tang H, Black S Front Cardiovasc Med. 2021; 8:719058.

PMID: 34568460 PMC: 8460911. DOI: 10.3389/fcvm.2021.719058.


The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.

Menazza S, Murphy E Circ Res. 2016; 118(6):994-1007.

PMID: 26838792 PMC: 5012719. DOI: 10.1161/CIRCRESAHA.115.305376.


[Regulation of uterine blood flow. I. Functions of estrogen and estrogen receptor α/β in the uterine vascular endothelium during pregnancy].

Mayra P, Rosalina V, Lopez G, Iruretagoyena J, Magness R Rev Chil Obstet Ginecol. 2015; 79(2):129-139.

PMID: 26113750 PMC: 4477512. DOI: 10.4067/S0717-75262014000200011.


Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.

Khalil R Biochem Pharmacol. 2013; 86(12):1627-42.

PMID: 24099797 PMC: 3840081. DOI: 10.1016/j.bcp.2013.09.024.